Delivery Order SPE2DB20D1100-SPE2DB25FE1PR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, valued at $1,497.08, represents a non-competitive award and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The order is scheduled for completion by September 16, 2025, with performance occurring at the...
- The Defense Logistics Agency awarded a $4,912.24 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by September 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,599.91 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive pharmaceutical product. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was awarded without set-aside restrictions through competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $3,216.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be completed by July 15, 2025, with services provided...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.96 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablet 28s, a hormonal contraceptive medication. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of June 20, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,455.71 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1PRDelivery Order
The Defense Logistics Agency awarded a $4,920.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's critical role in supporting federal pharmaceutical procurement needs across the Department of Defense and related healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, combined with its extensive pharmaceutical distribution infrastructure, positions it as a key vendor for ongoing military and veteran healthcare pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/29/25 |